Podcast Episodes

Back to Search
Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials
Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials

Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?

7 years, 5 months ago

Short Long
View Episode
Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA
Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

Are law-breaking pharma executives the new mob bosses? Can genome editing preventing heart attacks? And can the FDA regulate drug prices?

7 years, 5 months ago

Short Long
View Episode
Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms
Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms

Is Biogen bracing for a fight? What does Jack Daniels have to do with immunotherapy? And will "micro-dosing" light the way to actual therapies?

7 years, 5 months ago

Short Long
View Episode
Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup
Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

Who gets to be "influential"? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys?

7 years, 5 months ago

Short Long
View Episode
Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print
Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print

Who gets to "play God"? Can old technologies learn new tricks? And what does "drug price" even mean?

7 years, 6 months ago

Short Long
View Episode
Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst
Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst

How do you sell lefty ideas to righty politicians? What’s going on at Gilead Sciences? And why are biotech investors freaking out?

7 years, 6 months ago

Short Long
View Episode
Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound
Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound

What if pharma just charged less for drugs? Can speaking three syllables reveal whether you're depressed? And why is Snoop Dogg selling erectile dysf…

7 years, 6 months ago

Short Long
View Episode
Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges
Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

Why can't investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?

7 years, 6 months ago

Short Long
View Episode
Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores
Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores

Should Alzheimer's researchers just give up on amyloid plaques? What will a new drug mean for new moms with postpartum depression? And which coastal …

7 years, 7 months ago

Short Long
View Episode
Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen
Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen

Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos?

7 years, 7 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us